Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Protein Page:
DBH (human)

Overview
DBH Conversion of dopamine to noradrenaline. Homotetramer composed of two non-covalently bound disulfide-linked dimers. Activity is enhanced by nerve growth factor (in superior cervical ganglia and adrenal medulla). Trans-synaptic stimulation with reserpine, acetylcholine and glucocorticoids. Belongs to the copper type II ascorbate-dependent monooxygenase family. Note: This description may include information from UniProtKB.
Protein type: Apoptosis; Cell cycle regulation; EC 1.14.17.1; Membrane protein, integral; Amino Acid Metabolism - tyrosine; Oxidoreductase; Motility/polarity/chemotaxis
Chromosomal Location of Human Ortholog: 9q34
Cellular Component: cytoplasm; membrane
Molecular Function: catalytic activity; dopamine beta-monooxygenase activity
Biological Process: catecholamine biosynthetic process; synaptic transmission
Disease: Dopamine Beta-hydroxylase Deficiency, Congenital
Reference #:  P09172 (UniProtKB)
Alt. Names/Synonyms: DBH; DBM; Dopamine beta-hydroxylase; dopamine beta-hydroxylase (dopamine beta-monooxygenase); Dopamine beta-monooxygenase; DOPO; Soluble dopamine beta-hydroxylase
Gene Symbols: DBH
Molecular weight: 69,065 Da
Basal Isoelectric point: 5.97  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

DBH

Protein Structure Not Found.
Download PyMol Script
Download ChimeraX Script


STRING  |  cBioPortal  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  ENZYME  |  Phospho.ELM  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment



 LTP 

LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 HTP 

HTP: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 3 Y310‑p ALGAKAFyYPEEAGL
0 1 Y327‑p GGPGSSRyLRLEVHy
0 1 Y334‑p yLRLEVHyHNPLVIE
0 1 Y353‑p SSGIRLYyTAKLRRF
0 1 T422‑p LTGRKVVtVLVRDGR
0 1 S587‑p QPLPKVIstLEEPTP
0 1 T588‑p PLPKVIstLEEPTPQ
0 1 S603‑p CPTSQGRsPAGPTVV
  mouse

 
Y314 ALGAKAFYYPKEAGV
F331 GGPGSSPFLRLEVHY
Y338 FLRLEVHYHNPRKIQ
Y357 SSGIRLHYTATLRRY
T426 LTGRKVVTVLARDGQ
S591 QPLPKITSTLEEPTP
T592 PLPKITSTLEEPTPR
S607 CPIRQTQSPANPTVP
  rat

 
Y313 ALGAKAFYYPEEAGV
F330 GSSGSSRFLRLEVHY
Y337 FLRLEVHYHNPRNIQ
Y356 SSGIRLHYTASLRPN
T425 LTGRKVITVLARDGQ
S590 QPLPNITSAVEEPDP
A591 PLPNITSAVEEPDPR
G606 CPIRQTRGPAGPFVV
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.